I don't have MS, but this is GREAT news

Leukaemia drug can halt, reverse MS

Thu Oct 23, 5:26 am ET

LONDON (AFP) – Researchers at the University of Cambridge said Thursday they have found that a drug originally developed to treat leukaemia can halt and even reverse the debilitating effects of multiple sclerosis (MS).

In trials, alemtuzumab reduced the number of attacks in sufferers and also helped them recover lost functions, apparently allowing damaged brain tissue to repair so that individuals were less disabled than at the start of the study.

"The ability of an MS drug to promote brain repair is unprecedented," said Dr Alasdair Coles, a lecturer at Cambridge university's department of clinical neurosciences, who coordinated many aspects of the study.

"We are witnessing a drug which, if given early enough, might effectively stop the advancement of the disease and also restore lost function by promoting repair of the damaged brain tissue."

The MS Society, Britain's largest support charity for those affected by the condition, said it was "delighted" at the trial's results, which must be followed up with more research before the drug can be licensed.

"This is the first drug that has shown the potential to halt and even reverse the debilitating effects of MS and this news will rightly bring hope to people living with the condition day in, day out," said head of research Lee Dunster.

MS is an auto-immune disease that affects millions of people worldwide, including almost 100,000 in Britain and 400,000 in the United States.

It is caused by the body's immune system attacking nerve fibres in the central nervous system, and can lead to loss of sight and mobility, depression, fatigue and cognitive problems. There is no cure, and few effective treatments.

In the trial, 334 patients diagnosed with early-stage relapsing-remitting MS who had not previously been treated were given alemtuzumab or interferon beta-1a, one of the most effective licensed therapies for similar MS cases.

After three years, alemtuzumab was found to reduce the number of attacks the patients suffered by 74 percent over the other treatment, and reduce the risk of sustained accumulation of disability by 71 percent over interferon beta-1a.

Many individuals who took alemtuzumab also recovered some of their lost functions, becoming less disabled by the end, while the disabilities of the other patients worsened, the study in the New England Journal of Medicine said.

Alastair Compston, professor of neurology and head of the clinical neurosciences department at Cambridge, said alemtuzumab was the "most promising" experimental drug for the treatment of MS.

He expressed hope that further trials "will confirm that it can both stabilise and allow some recovery of what had previously been assumed to be irreversible disabilities".

Alemtuzumab was developed in Cambridge and has been licensed for the treatment of chronic lymphocytic leukaemia.

Comments

Post a Comment

Popular posts from this blog

Workers free dog trapped in sewer pipe

MANKATO, Minn. (AP) -- The sound of barking underneath a street Tuesday led a team of city workers to a dog trapped in a narrow culvert - and you might say they used a backward approach to rescue the mutt. The sickly, scared dog was about 50 feet from the nearest entry point, but since the culvert was just 15 inches in diameter, the workers couldn't fit into it themselves. Not even offers of food could draw out the dog. "He was exhausted," said Tony Talamantez, a public works foreman. Then Talamantez and his colleagues had an idea. They rigged up a long video camera used to inspect drain pipes, and approached the dog from the back. They used the camera to nugdge the dog forward until he reached an entry point big enough for a person to pull him out. The camera recorded the rescue, showing the dog scampering ahead in fits and starts as the camera pokes him in the rear end. The dog wore no tags, only a worn collar. But Julia Gosen, animal control officer for the city, said
Read more

Axe Me A Question

Go ahead and ask. Ask the questions you always wanted to ask someone in a wheelchair. Nothing is too embarrassing. You might as well ask me on this blog since you are somewhat anonymous and don't have to look me in the eye. What have you always wanted to ask someone in a wheelchair? Here, I'll start: Q: "Hi, my name is LaLaundria! I wanted to know how do you take a shower?" A: Well, LaLaundria, I sit down. On a shower chair. I have grab-bars installed in my shower/tub and my commode rooms to give me extra balance. A shower chair is a hard plastic chair made to fit in showers and tubs. I have a shower massage type shower head that helps get the water closer to my hair. Howze that? Ask away, no question is off limits! (Oh Jeez, what am I getting myself into!)
Read more

Crested Geckos - great pet for the disabled

Image
A few weekends ago at the Austin Reptile Expo, I had the opportunity to meet a really neat woman who breeds and sells Crested Geckos. Since I have lizards as pets and have written before about how great they are as pets for disabled folks, I thought I'd write about the Crested Gecko in particular. The woman I speak of is Kati of Kati's Crested's . She's here in Austin, TX. I had never held a crested gecko before this Expo, but I had seen them in a tank at a local reptile store. They are very kewl lizards! Soft to the touch, almost like suede. The one I held jumped from one hand to the other and held on with it's prehensile tail! The crested gecko originates from New Caledonia (an island east of Australia). Adults range from 6-9" in total length. In the wild, they are nocturnal, arboreal animals living in the forests. Most wild specimens are tail-less, presumably because they dropped their tails while escaping from a predator. All of Kati's cresteds are c
Read more